Teicoplanin Injection IP, sold under the brand Satcopin-400 Injection, is a glycopeptide antibiotic used for treating severe bacterial infections, particularly those resistant to other antibiotics. Administered intravenously, it targets Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Satcopin-400 Injection offers prolonged antibacterial activity with less frequent dosing due to its long half-life. It is essential in hospital settings for treating complicated infections, ensuring effective therapy against resistant pathogens.Available in PCD Franchise for injectable range and third party manufacturing.